Q-Line Biotech
add_icon

Q-Line Biotech

539.45
-0.90
(-0.17%)
Market Cap
1,258.44 Cr
PE Ratio
22.62
Volume
1,35,600.00
Day High - Low
561.95 - 533.40
52W High-Low
600.00 - 343.00
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
1,258.44 Cr
EPS
34.79
PE Ratio
22.62
PB Ratio
2.58
Book Value
209.24
EBITDA
97.06
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
12.91
Debt to Equity
0.75
Forecast For
Actual
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,614.30
#1 16,362.46
52.76
#1 1,875.26
6.61
#1 326
-29.19
52.62
290.25
1,544.31
110.65
422.51
3.45
16
-58.82
69.16
539.45
#3 1,258.44
#3 22.62
#4 341.74
#8 5.93
#2 56
#1 750.00
53.99
214.64
1,179.71
42.20
271.50
12.00
22
134.88
41.13
452.05
804.40
28.41
292.67
56.84
30
-
41.47
156.81
697.03
#1 18.78
410.77
22.29
36
46.36
49.95
380.00
659.05
66.00
278.87
10.97
10
-68.29
45.83
351.10
510.37
27.93
231.81
#1 107.34
19
-
41.28
380.05
456.22
22.57
71.81
7.02
21
13.73
45.96
144.50
275.13
53.94
54.75
-59.83
5
-
33.04
Growth Rate
Revenue Growth
5.93 %
Net Income Growth
127.10 %
Cash Flow Change
-
ROE
-3.44 %
ROCE
15.00 %
EBITDA Margin (Avg.)
8.34 %

Quarterly Financial Results

Quarterly Financials
Dec 2025
Mar 2026
Revenue
90
111
Expenses
60
77
EBITDA
31
34
Operating Profit %
33 %
29 %
Depreciation
2
5
Interest
5
6
Profit Before Tax
23
23
Tax
6
6
Net Profit
17
17
EPS in ₹
10.68
10.46

Balance Sheet

Balance Sheet
2023
2024
2025
2026
Total Assets
252
339
456
559
Fixed Assets
23
60
74
161
Current Assets
176
199
265
344
Capital Work in Progress
12
19
63
15
Investments
0
0
0
95
Other Assets
217
260
319
0
Total Equity & Liabilities
252
339
456
559
Current Liabilities
108
140
179
210
Non Current Liabilities
16
37
86
103
Total Equity
127
162
190
246
Reserve & Surplus
126
160
188
230
Share Capital
2
2
2
16

Cash Flow

Cash Flow
2023
2024
2025
Net Cash Flow
25
-52
-7
Investing Activities
-26
-45
-59
Operating Activities
25
-24
-1
Financing Activities
26
17
53

Share Holding

% Holding
Sept 2025
May 2026
Promoter
96.77 %
67.51 %
FIIs
0.00 %
1.67 %
DIIs
0.00 %
10.14 %
Government
0.00 %
0.00 %
Public / Retail
0.00 %
15.97 %
Others
3.23 %
4.70 %
No of Share Holders
0
3,497

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
17 Jun 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
17 Jun 2026 504.35 502.15

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Abakkus Small Cap Fund Direct-Growth
0.00%
0
0.00%
-1.72%

Technical Indicators

RSI(14)
Neutral
54.26
ATR(14)
Less Volatile
29.22
STOCH(9,6)
Neutral
40.98
STOCH RSI(14)
Oversold
0.00
MACD(12,26)
Bearish
0.00
ADX(14)
Weak Trend
0.00
UO(9)
Bullish
0.00
ROC(12)
Uptrend And Accelerating
2.76
WillR(14)
Neutral
-57.36